Hypertonic saline for cerebral edema and elevated intracranial pressure

Area of Science:

• Neurosurgery
• Critical Care Medicine
• Pharmacology

Background:

• Elevated intracranial pressure (ICP) is a critical condition in various neurological disorders.
• Current treatments like hyperventilation and mannitol have limitations and potential side effects.
• Hypertonic saline (HS) solutions have emerged as a potential therapeutic option for managing ICP.

Purpose of the Study:

• To review the efficacy and safety of hypertonic saline (HS) solutions in reducing intracranial pressure (ICP).
• To explore the potential mechanisms of action for HS in managing ICP.
• To identify areas requiring further research regarding HS administration and its comparative effectiveness.

Main Methods:

• Review of existing animal models and human studies on HS for ICP reduction.
• Analysis of reported complications and adverse events in human studies.
• Comparison of different HS concentrations and infusion methods (bolus vs. continuous).

Main Results:

• HS solutions demonstrated efficacy in reducing ICP across various conditions, including refractory cases.
• No significant complications like central pontine myelinolysis or intracranial hemorrhage were reported in human studies.
• Current data is insufficient to recommend specific HS concentrations or administration methods over others.

Conclusions:

• HS is a promising agent for ICP reduction with a favorable safety profile in humans.
• Further research is needed to elucidate HS mechanisms, optimal dosing, and administration strategies.
• Comparative studies are essential to determine HS's relative efficacy against established treatments like mannitol.